|
JAMA Network Open |
Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations |
1 |
Yes |
3/7/2025 |
|
JAMA Network Open |
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge - A Cohort Study and Randomized Comparative Effectiveness Trial |
1 |
Yes |
8/1/2025 |
|
JAMA Network Open |
Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Efficacy of Niclosamide vs Placebo in SARS-CoV-2 Respiratory Viral Clearance, Viral Shedding, and Duration of Symptoms Among Patients With Mild to Moderate COVID-19 - A Phase 2 Randomized Clinical Trial |
1 |
Yes |
2/11/2025 |
|
JAMA Network Open |
Emotional Exhaustion Among US Health Care Workers Before and During the COVID-19 Pandemic, 2019-2021 |
1 |
Yes |
9/23/2025 |
|
JAMA Network Open |
Enhancing Postmarketing Surveillance of Medical Products With Large Language Models |
1 |
Yes |
8/16/2027 |
|
JAMA Network Open |
Estimated Clinical Trial Capacity of Sites Participating in the COVID-19 Convalescent Plasma Expanded Access Program |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Messenger RNA Vaccination Against SARS-CoV-2 Infection Among Older Male Veterans Health Administration Enrollees, January to September 2021 |
1 |
Yes |
12/21/2024 |
|
JAMA Network Open |
Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes |
1 |
Yes |
9/23/2025 |
|
JAMA Network Open |
Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA Vaccinated and Nonvaccinated Individuals in Quebec, Canada |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England |
1 |
Yes |
11/7/2025 |
|
JAMA Network Open |
Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the Pandemic |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Estimation of the Timing and Intensity of Reemergence of Respiratory Syncytial Virus Following the COVID-19 Pandemic in the US |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
Evaluation of Aerosol Particle Leak and Standard Surgical Mask Fit With 3 Elastomeric Harness Designs |
1 |
Yes |
2/2/2025 |
|
JAMA Network Open |
Evaluation of Age Patterns of COVID-19 Mortality by Race and Ethnicity From March 2020 to October 2021 in the US |
1 |
Yes |
5/31/2025 |
|
JAMA Network Open |
Evaluation of an Optical Defocus Treatment for Myopia Progression Among Schoolchildren During the COVID-19 Pandemic |
1 |
Yes |
1/14/2025 |
|
JAMA Network Open |
Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan |
1 |
Yes |
3/7/2025 |
